QQ客服 官方微博 反馈留言

	Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials
	Liu, Xiaoping; He, Colin K.; Meng, Xiangyu; He, Li; Li, Kaili; Liang, Qing; Shao, Liang; Liu, Shangqin
刊名	ONCOTARGETS AND THERAPY
	2015
卷号	8
关键词	multiple myeloma post-transplantation therapy bortezomib-based regimen
ISSN号	1178-6930
DOI	10.2147/OTT.S84828
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4087714
专题	武汉大学
推荐引用方式 GB/T 7714	Liu, Xiaoping,He, Colin K.,Meng, Xiangyu,et al. Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials[J]. ONCOTARGETS AND THERAPY,2015,8.
APA	Liu, Xiaoping.,He, Colin K..,Meng, Xiangyu.,He, Li.,Li, Kaili.,...&Liu, Shangqin.(2015).Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials.ONCOTARGETS AND THERAPY,8.
MLA	Liu, Xiaoping,et al."Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials".ONCOTARGETS AND THERAPY 8(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。